Related Articles
Splice variants of lysosome‑associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells
5‑fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma
QPCT regulation by CTCF leads to sunitinib resistance in renal cell carcinoma by promoting angiogenesis
Reversible posterior leukoencephalopathy syndrome during sunitinib therapy for metastatic renal cell carcinoma
Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma